Rockefeller Capital Management L.P. Voyager Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$5.57 - $7.47 $2,205 - $2,958	396 Added 155.91%	650 $3,000
Q2 2022 Aug 12, 2022	BUY	$4.82 - $10.09 $1,224 - $2,562	254 New	254 $1,000
Q2 2020 Aug 12, 2020	SELL	$8.05 - $14.21 $39,163 - $69,131	-4,865 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$6.8 - $14.66 $7,242 - $15,612	-1,065 Reduced 17.96%	4,865 $45,000
Q4 2019 Feb 07, 2020	SELL	$12.82 - $16.85 $1,051 - $1,381	-82 Reduced 1.36%	5,930 $83,000
Q3 2019 Nov 12, 2019	SELL	$16.31 - $28.29 $2,250 - $3,904	-138 Reduced 2.24%	6,012 $103,000
Q2 2019 Aug 09, 2019	BUY	$19.18 - $27.88 $117,957 - $171,462	6,150 New	6,150 $167,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.